Questions Raised About Antiplatelet Therapy in Chronic Kidney Disease
Forbes
Many people develop chronic kidney disease (CKD) as they grow older, and many people with CKD take antiplatelet agents to prevent cardiovascular events. However, the efficacy of antiplatelet therapy in CKD has not been examined, despite the fact that ...
Annals of Internal Medicine tip sheet for March 20, 2012, issueEurekAlert (press release)
Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding ...Annals of Internal Medicine
AIM: Antiplatelets may cause more harm than good in CKD patientsCardiovascular Business

all 5 news articles »